“Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood.”, Open Forum Infect Dis, vol. 6, no. 1, p. ofy352, 2019.
, “Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.”, J Infect Dis, vol. 211, no. 6, pp. 870-8, 2015.
, “Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.”, Lancet, vol. 391, no. 10120, pp. 563-571, 2018.
, “Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised).”, BMC Res Notes, vol. 6, p. 177, 2013.
, “Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules.”, Pediatrics, vol. 137, no. 2, p. e20152603, 2016.
,